Serum Anti-heat Shock Protein 27 Antibody Titers in Patients With Dyslipidemia: A Population-based Case-control Study

Fatemeh Sadabadi; Maryam Shahi; Susan Darroudi; Azam Rastgar Moghadam; Sahar Heidari-Bakavoli; Asma Porsa; Sara  Saffar Soflaei; Habibollah Esmaily; Mohsen Moohebati; Ghodratollah Salehi Sangani; Gordon A . Ferns; Bibi Razieh Hoseini Farash; Majid Ghayour-Mobarhan

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us

Authors Guide Submit Manuscript

Serum Anti-heat Shock Protein 27 Antibody Titers in Patients With Dyslipidemia: A Population-based Case-control Study

Author(s):

Fatemeh Sadabadi¹,

Maryam Shahi

²,

Susan Darroudi³,

Azam Rastgar Moghadam³,

Sahar Heidari-Bakavoli⁴,

Asma Porsa³,

Sara Saffar Soflaei³,

Habibollah Esmaily

,

Mohsen Moohebati⁵,

Ghodratollah Salehi Sangani⁶,

Gordon A . Ferns,

Bibi Razieh Hoseini Farash

⁶,

Majid Ghayour-Mobarhan

^3,*

1Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

2Blood Borne Infections Research Center, Academic Center for Education, Culture and Research, Razavi Khorasan Branch, Mashhad, Iran.

3Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

4Department of Biology, School of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.

5Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

6Department of Parasitology and Mycology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Journal of Inflammatory Diseases:Vol. 26, issue 1; 1-8

Article type:Research Article

How to Cite:Fatemeh SadabadiMaryam ShahiSusan DarroudiAzam Rastgar MoghadamSahar Heidari-BakavoliAsma PorsaSara Saffar SoflaeiHabibollah EsmailyMohsen MoohebatiGhodratollah Salehi SanganiGordon A . FernsBibi Razieh Hoseini FarashMajid Ghayour-Mobarhanet al.Serum Anti-heat Shock Protein 27 Antibody Titers in Patients With Dyslipidemia: A Population-based Case-control Study.J Inflamm Dis.26(1):e156302.

Abstract

Background: Heat shock protein 27 (HSP27) is found in several cell types of adults, such as cardiomyocytes, and endothelial cells. It is expressed in response to different cellular stress conditions. HSP27 decreases the levels of reactive oxygen species (ROS) and dyslipidemia is closely associated with increased endothelial production of reactive oxygen species (ROS). Objective: Higher serum HSP27 antigen and anti-HSP27 antibodies have been reported in patients with unstable angina and myocardial infarction Methods: This population-based case-control study was conducted in 2018. We investigated serum anti-HSP27 antibody titers in all participants with dyslipidemia from the Mashhad stroke and heart atherosclerotic disorder (MASHAD) study (n=8141) and those who were healthy in terms of dyslipidemia (n=1637) using an in-house enzyme-linked immune sorbent assay (ELISA) in individuals with dyslipidemia. Findings: Anti-HSP27 titers were significantly lower in individuals with dyslipidemia compared to people without dyslipidemia (P=0.036). Conclusion: Our results revealed that the anti-HSP27 antibody titer was lower in the participants with dyslipidemia than in the negative group. However, there may be a confounding effect of drug therapy. In a subgroup of dyslipidemic subjects, we observed lower anti-HSP27 antibody titers in patients treated with some drugs (statins or corticosteroids, non-steroidal anti-inflammatory drugs [NSAIDs], or anti-diabetic and anti-hypertensive) compared to subjects untreated with these drugs.

Keywords

Serum anti-heat shock protein 27 antibody

Dyslipidemia

Stroke and Heart Atherosclerotic Disorder study cohort

comments